Dwarfism
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Meet the diagnostic criteria for short stature; Sign informed consent; Plan to receive GH treatment; Plan to attend a study hospital for treatment; Plan to participate in multiple follow-up visits over 12 months during the course of treatment.
Exclusion criteria
Exclusion criteria: Patients with short stature due to secondary hypothalamic pituitary disease; Patients with short stature due to chronic systemic diseases such as liver and kidney; Patients receiving corticosteroids, thyroid hormones, estrogen and other drugs that affect height; Patients with past or current malignant diseases; The presence of any factors deemed unsuitable for inclusion in the study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Growth reaction; | — |
Secondary
| Measure | Time frame |
|---|---|
| Genomic data;Image omics data;Metabolomics data;Environmental exposure omics; | — |
Countries
China
Contacts
Children's Hospital of Nanjing Medical University